Literature DB >> 19103650

Regulation of peroxisome proliferator-activated receptor-alpha by MDM2.

Lakshmi Gopinathan1, Daniel B Hannon, Jeffrey M Peters, John P Vanden Heuvel.   

Abstract

Peroxisome proliferator-activated receptor-alpha (PPARalpha) belongs to the nuclear receptor (NR) family of transcription factors and regulates lipid and glucose metabolism. Like other NRs, the regulation of gene expression by PPARalpha depends on cofactor recruitment to the transcription complex and multiple protein-protein interactions. In this study, Murine Double Minute 2 (MDM2), an E3 ubiquitin ligase, is identified as a PPARalpha-interacting protein that regulates PPARalpha transcriptional activity. MDM2 modulated the transcriptional activity of PPARalpha and PPARbeta/delta, but not PPARgamma in reporter assays. Knockdown of MDM2 by small interfering RNA in rat hepatoma cells inhibited ligand-induced mRNA levels of several PPARalpha target genes involved in lipid metabolism. MDM2 associated with PPARalpha on target gene promoters, and this association increased in response to Wy14,643 treatment. MDM2 interacted with PPARalpha and this interaction occurred with the A/B domain of PPARalpha. Coexpression of MDM2 increased PPARalpha ubiquitination and the E3 ubiquitin ligase activity of MDM2 affected PPARalpha protein expression and transcriptional activity. MDM2 expression was decreased in response to clofibrate in wild-type (WT), but not in PPARalpha null mice, indicating a PPARalpha-dependent regulation. These studies identify a role for MDM2 in regulating PPARalpha-mediated pathways of lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103650      PMCID: PMC2644403          DOI: 10.1093/toxsci/kfn260

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  45 in total

1.  Regulation of HDM2 activity by the ribosomal protein L11.

Authors:  Marion A E Lohrum; Robert L Ludwig; Michael H G Kubbutat; Mary Hanlon; Karen H Vousden
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

2.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

3.  Regulation of the mdm2 oncogene by thyroid hormone receptor.

Authors:  J S Qi; Y Yuan; V Desai-Yajnik; H H Samuels
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 4.  Mdm2 in growth signaling and cancer.

Authors:  Yaara Levav-Cohen; Sue Haupt; Ygal Haupt
Journal:  Growth Factors       Date:  2005-09       Impact factor: 2.511

5.  Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer.

Authors:  Masao Hori; Jiro Shimazaki; Satoshi Inagawa; Masayuki Itabashi; Mitsuo Hori
Journal:  Breast Cancer Res Treat       Date:  2002-01       Impact factor: 4.872

6.  Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

Authors:  J M Peters; R C Cattley; F J Gonzalez
Journal:  Carcinogenesis       Date:  1997-11       Impact factor: 4.944

7.  Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.

Authors:  Debie J Hoivik; Charles W Qualls; Rosanna C Mirabile; Neal F Cariello; Carie L Kimbrough; Heidi M Colton; Steven P Anderson; Michael J Santostefano; Ronda J Ott Morgan; Ray R Dahl; Alan R Brown; Zhiyang Zhao; Paul N Mudd; William B Oliver; H Roger Brown; Richard T Miller
Journal:  Carcinogenesis       Date:  2004-05-06       Impact factor: 4.944

Review 8.  Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.

Authors:  Sagar Sengupta; Bohdan Wasylyk
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

View more
  13 in total

1.  Do Mesenchymal Stem Cells Derived From Atypical Lipomatous Tumors Have Greater Differentiation Potency Than Cells From Normal Adipose Tissues?

Authors:  Hiroyuki Inatani; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Takashi Higuchi; Kensaku Abe; Yuta Taniguchi; Satoshi Yamada; Kiyofumi Asai; Takanobu Otsuka; Hiroyuki Tsuchiya
Journal:  Clin Orthop Relat Res       Date:  2017-02-02       Impact factor: 4.176

Review 2.  The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.

Authors:  Kristine M Wadosky; Monte S Willis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

Review 3.  Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

Authors:  Kannan Badri Narayanan; Manaf Ali; Barry J Barclay; Qiang Shawn Cheng; Leandro D'Abronzo; Rita Dornetshuber-Fleiss; Paramita M Ghosh; Michael J Gonzalez Guzman; Tae-Jin Lee; Po Sing Leung; Lin Li; Suidjit Luanpitpong; Edward Ratovitski; Yon Rojanasakul; Maria Fiammetta Romano; Simona Romano; Ranjeet K Sinha; Clement Yedjou; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Elizabeth P Ryan; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Hosni K Salem; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Seo Yun Kim; William H Bisson; Leroy Lowe; Hyun Ho Park
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

4.  The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.

Authors:  Jessica E Rodríguez; Jie-Ying Liao; Jun He; Jonathan C Schisler; Christopher B Newgard; Doreen Drujan; David J Glass; C Brandon Frederick; Bryan C Yoder; David S Lalush; Cam Patterson; Monte S Willis
Journal:  Mol Cell Endocrinol       Date:  2015-06-25       Impact factor: 4.102

5.  Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin.

Authors:  Urmila Maitra; Liwu Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-01       Impact factor: 8.311

6.  Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation.

Authors:  Anne Bugge; Susanne Mandrup
Journal:  PPAR Res       Date:  2010-08-31       Impact factor: 4.964

Review 7.  Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Angela Nigro; Valentina Lucia La Rosa; Paola Rossetti; Agnese Maria Chiara Rapisarda; Sandro La Vignera; Rosita Angela Condorelli; Francesco Corrado; Massimo Buscema; Rosario D'Anna
Journal:  PPAR Res       Date:  2016-12-28       Impact factor: 4.964

8.  MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling.

Authors:  Divya Venkatesh; Nicholas A O'Brien; Fereshteh Zandkarimi; David R Tong; Michael E Stokes; Denise E Dunn; Everett S Kengmana; Allegra T Aron; Alyssa M Klein; Joleen M Csuka; Sung-Hwan Moon; Marcus Conrad; Christopher J Chang; Donald C Lo; Angelo D'Alessandro; Carol Prives; Brent R Stockwell
Journal:  Genes Dev       Date:  2020-02-20       Impact factor: 11.361

9.  Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1.

Authors:  Zilong Zhao; Daqian Xu; Zheng Wang; Lin Wang; Ruomei Han; Zhenzhen Wang; Lujian Liao; Yan Chen
Journal:  Hepatology       Date:  2018-04-26       Impact factor: 17.425

Review 10.  Functional Regulation of PPARs through Post-Translational Modifications.

Authors:  Reinhard Brunmeir; Feng Xu
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.